AS ONE Corporation (JP:7476)
:7476
Want to see JP:7476 full AI Analyst Report?
Top Page
AS ONE
(7476)
Select Model
Select Model
Rating:69Neutral
Price Target:
¥2,174.00
▼(-11.98% Downside)
Action:Downgraded
Date:05/15/26
The score is driven primarily by strong financial fundamentals—especially a conservative, low-leverage balance sheet and steady profitability—partly offset by weaker cash-flow consistency. Technical signals are notably bearish with the price below key moving averages and negative momentum, while a moderate P/E and solid dividend yield support the valuation component.
Positive Factors
Conservative Balance Sheet
Very low leverage and substantial equity give the company durable financial flexibility: it can fund working capital, modest capex, dividends or opportunistic M&A without stressing solvency. Low debt reduces interest risk in downturns and supports long-term stability.
Negative Factors
Uneven Cash-Flow Conversion
Although free cash flow is positive, weak operating cash conversion and volatile FCF reduce predictability of internally generated funds. This constrains the firm's ability to reliably fund capex, smooth dividends, or pursue strategic investments without external financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Very low leverage and substantial equity give the company durable financial flexibility: it can fund working capital, modest capex, dividends or opportunistic M&A without stressing solvency. Low debt reduces interest risk in downturns and supports long-term stability.
Read all positive factors
AS ONE (7476) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥146.59B
Dividend Yield2.6%
Average Volume (3M)216.80K
Price to Earnings (P/E)17.2
Beta (1Y)0.56
Revenue Growth6.70%
EPS Growth11.73%
CountryJP
Employees711
SectorHealthcare
Sector Strength45
IndustryMedical - Distribution
Share Statistics
EPS (TTM)119.31
Shares Outstanding75,012,540
10 Day Avg. Volume233,440
30 Day Avg. Volume216,803
Financial Highlights & Ratios
PEG Ratio1.47
Price to Book (P/B)2.21
Price to Sales (P/S)1.42
P/FCF Ratio35.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)135.47
Revenue Forecast (FY)¥116.65B
AS ONE Business Overview & Revenue Model
Company Description
AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally. It offers scientific instruments comprising temperature/humidity control and me...
How the Company Makes Money
AS ONE primarily makes money by selling and distributing scientific and industrial supplies to universities, research institutes, hospitals, and private-sector manufacturers. Its revenue model is centered on (1) product sales of laboratory consuma...
AS ONE Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
62
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 105.22B | 110.70B | 103.75B | 95.54B | 91.42B | 86.95B |
| Gross Profit | 31.93B | 33.47B | 31.32B | 29.25B | 28.45B | 25.54B |
| EBITDA | 13.78B | 14.66B | 13.39B | 12.26B | 13.04B | 11.07B |
| Net Income | 8.55B | 9.18B | 8.23B | 7.50B | 8.11B | 7.20B |
Balance Sheet | ||||||
| Total Assets | 96.79B | 102.42B | 101.72B | 95.83B | 97.48B | 96.11B |
| Cash, Cash Equivalents and Short-Term Investments | 20.52B | 22.14B | 22.57B | 13.89B | 18.61B | 19.22B |
| Total Debt | 6.58B | 4.75B | 7.21B | 3.65B | 6.27B | 3.19B |
| Total Liabilities | 29.24B | 31.24B | 35.01B | 31.17B | 33.51B | 29.95B |
| Stockholders Equity | 67.55B | 71.18B | 66.71B | 64.66B | 63.97B | 66.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.42B | 8.11B | 5.55B | 6.40B | 8.21B |
| Operating Cash Flow | 0.00 | 6.47B | 9.31B | 6.50B | 6.97B | 8.84B |
| Investing Cash Flow | 0.00 | -2.47B | 850.00M | -1.93B | -367.98M | 591.15M |
| Financing Cash Flow | 0.00 | -8.05B | -659.00M | -9.04B | -7.28B | -5.16B |
AS ONE Technical Analysis
Negative
2470.00
Price Trends
2190.46
Negative
2263.60
Negative
2359.03
Negative
Market Momentum
-41.47
Positive
44.31
Neutral
40.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7476, the sentiment is Negative. The current price of 2470 is above the 20-day moving average (MA) of 2124.90, above the 50-day MA of 2190.46, and above the 200-day MA of 2359.03, indicating a bearish trend. The MACD of -41.47 indicates Positive momentum. The RSI at 44.31 is Neutral, neither overbought nor oversold. The STOCH value of 40.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7476.
AS ONE Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥146.59B | 17.17 | 12.55% | 2.60% | 6.70% | 11.73% | |
66 Neutral | ¥423.73B | 11.01 | 6.92% | 2.69% | 4.83% | 56.24% | |
64 Neutral | ¥185.99B | 16.64 | 9.53% | 2.19% | 5.89% | -9.94% | |
61 Neutral | ¥249.58B | 16.30 | ― | 1.92% | 4.29% | 3.92% | |
54 Neutral | ¥281.59B | 18.74 | 4.38% | 2.03% | 2.47% | 164.11% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | ¥130.02B | 279.88 | 2.42% | 3.73% | 0.78% | -95.37% |
* Healthcare Sector Average
JP:7476
AS ONE
2,064.00
-102.63
-4.74%
JP:2784
Alfresa Holdings
2,220.50
356.13
19.10%
JP:8086
Nipro
1,726.50
460.87
36.41%
JP:3360
Ship Healthcare Holdings
2,137.00
393.32
22.56%
JP:6523
PHC Holdings Corp.
1,026.00
112.06
12.26%
JP:6849
Nihon Kohden Corporation
1,495.00
-300.79
-16.75%
AS ONE Corporate Events
AS ONE Raises Annual Dividend Payout as Progressive Policy Takes Hold
May 13, 2026
AS ONE CORPORATION’s board has approved a year-end dividend of ¥34 per share for the fiscal year ended March 31, 2026, up ¥2 from its most recent forecast and unchanged from the prior year’s year-end level. This payout from r...
AS ONE Books 28.5% April Sales Surge on Strong Demand for Plastic Consumables
May 13, 2026
AS ONE Corporation reported a sharp rise in preliminary standalone net sales for April 2026, with revenue reaching ¥10,572 million, up 28.5% year on year. The company noted that these figures, compiled for its three major segments, are indica...
AS ONE Lifts Profit and Dividend on Higher Sales, Sees Moderate Earnings Ahead
May 13, 2026
AS ONE reported solid results for the fiscal year ended March 31, 2026, with net sales rising 6.7% to ¥110.7 billion and profit attributable to owners of parent climbing 11.5% to ¥9.18 billion, supported by improved operating and ordinar...
AS ONE Hits Record March Sales on Surging Consumables Demand
Apr 8, 2026
AS ONE reported that March 2026 net sales rose 16.2% year-on-year, surpassing 10 billion yen in a single month for the first time, with sales per business day up 10.7%. Growth was supported by robust large-scale projects at the fiscal year-end and...
AS ONE Retires 340,000 Treasury Shares to Streamline Capital Structure
Mar 31, 2026
AS ONE CORPORATION has completed the retirement of 340,000 shares of its common stock, representing 0.45% of the total shares outstanding before the transaction, pursuant to Article 178 of the Companies Act. Effective March 31, 2026, the move redu...
AS ONE Posts February Sales Growth on Strong Scientific and Industrial Demand
Mar 12, 2026
AS ONE Corporation reported a 5.1% year-on-year increase in February 2026 net sales per day, underscoring solid growth in its core scientific and industrial supply businesses. The company highlighted that consumables demand is sensitive to the num...
AS ONE to Cancel Treasury Shares in Capital Efficiency Move
Mar 11, 2026
AS ONE CORPORATION announced it will cancel 340,000 shares of its common stock, representing 0.45% of its issued shares, under Article 178 of the Companies Act of Japan, with the effective date set for March 31, 2026. Following the cancellation, t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.